2Patel R, Portela D, Badley AD, et al. Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation[J]. Transplantation, 1996, 62: 926-934.
3Carillo-Munoz AJ, Quindos G, Tur C, et al. In vitro antifungal actilvity of liposomal nystatin in comparison with nystatin, amphotericin B cholesteryl sulfate, liposomal amphotericin B, amphotericin B lipid complex, amphotericin B desoxycholate, fluxonazole, and itraconazole[J]. J Antimicrob Chemother, 1999, 44:397-401.
4Johnson EM,Ojwang JO,Szekly A, et al. Comparison of in vitro antifungal activities of free and liposome-encapsulated nystatin with those of four amphotericin B formulations[J].Antimicrob Agents Chemother, 1998, 42: 1412-1416.
5Oakley KL, Moore CB,Denning DW. Comparison of in vitro activity of liposomal nystatin against aspergillus species with those of nystatin, amphotericin B (AB) deoxycholate, AB colloidal dispersion, liposomal AB, AB lipid complex, and itraconazole[J]. Antimicrob Agents Chemother, 1999, 43:1264-1266.
6Quindos G, Carrillo-Munoz AJ, Ruesga MT, et al. In vitro activity of a new liposomalnystatin formulation against opportunistic fungal pathogens[J]. Eur J Clin Microbiol Infect Dis 2000; 19: 645-648.
7Groll AH,Petraitis V,Petraitiene R, et al. Safety and efficacy of multilamellar liposomal nystatin against disseminated candidiasis in persistently neutropenic rabbits[J]. Antimicrob Agents Chemother, 1999, 43 : 2463-2467.
8Groll AH, Gonzalez CE, Giri N, et al. Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits: efficacy, safety and non-compartmental pharmacokinetics[J]. J. Antimicrob Chemother, 1999, 43:95-103.
9Denning DW, Warn P. Dose range evaluation of liposomal mystatin and comparisons with amphotericin B and amphotericin B lipid complex in temporarily neutronpenic mice infected with an isolate of Aspergillus fumigatus with reduced susceptibility to amphotericin B[J]. Antimicrob Agents Chemother,1999, 43 :2592-2599.
10Wallace TL, Paetznick V, Cossum PA,et al. Activity of liposomal nystatin against disseminated Aspergillus fumigatus infection in neutropenic mice. Antimicrob[J]. Agents Chemother. 1997, 41: 2238-2243.
